Predictive Value of Serum Autotaxin for Hepatocellular Carcinoma Recurrence After Curative Radiofrequency Ablation

ABSTRACT Background Despite recent treatment advancements, the high recurrence rate of hepatocellular carcinoma (HCC) following curative therapy remains a significant challenge. Autotaxin (ATX) is a key biomarker in chronic liver disease that has a yet unclarified role in predicting HCC recurrence....

Celý popis

Podrobná bibliografie

Hlavní autoři:	Takanobu Iwadare, Hiroyuki Kobayashi, Takefumi Kimura, Taiki Okumura, Taro Nakajima, Shun‐ichi Wakabayashi, Yuki Yamashita, Naoyuki Fujimori, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Takuro Uchida, Takeji Umemura, Naoki Tanaka
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-01-01
Edice:	Cancer Medicine
Témata:	autotaxin biomarker hepatocellular carcinoma radiofrequency ablation recurrence
On-line přístup:	https://doi.org/10.1002/cam4.71506
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!